Видео ютуба по тегу Biogen Inc

Biogen CEO Christopher Viehbacher breaks down his outlook for '23
Biogen CEO Christopher Viehbacher breaks down his outlook for '23
Biogen Alzheimer's drug could get Medicare coverage in 2025 if approved, says Dr. Scott Gottlieb
Biogen Alzheimer's drug could get Medicare coverage in 2025 if approved, says Dr. Scott Gottlieb
Анализ запасов биогенных компаний – как анализировать запасы биотехнологических компаний
Анализ запасов биогенных компаний – как анализировать запасы биотехнологических компаний
Biogen shares soar on landmark Alzheimer's data
Biogen shares soar on landmark Alzheimer's data
$BIIB Biogen Inc Q3 2025 Earnings Conference Call
$BIIB Biogen Inc Q3 2025 Earnings Conference Call
Biogen Inc. - Episode #174
Biogen Inc. - Episode #174
Biogen 2021 Year in Review
Biogen 2021 Year in Review
2025 WMIF | Fireside Chat | Focus on Biogen | Chris Viehbacher
2025 WMIF | Fireside Chat | Focus on Biogen | Chris Viehbacher
Biogen Inc BIIB Q3 2025 Earnings Call
Biogen Inc BIIB Q3 2025 Earnings Call
20 years of excellence | Biogen Brand Video
20 years of excellence | Biogen Brand Video
What’s The Controversy Behind Biogen’s Alzheimer’s Drug?
What’s The Controversy Behind Biogen’s Alzheimer’s Drug?
Why Biogen Agreed to Acquire Reata for $7.3 Billion
Why Biogen Agreed to Acquire Reata for $7.3 Billion
Biogen Pharmaceuticals Ltd.
Biogen Pharmaceuticals Ltd.
A Look at Biogen’s Newest Manufacturing Facility in Switzerland
A Look at Biogen’s Newest Manufacturing Facility in Switzerland
Here's What You Need to Know About Biotech Giant Biogen
Here's What You Need to Know About Biotech Giant Biogen
BIIB Stock | Biogen Inc Q3 2025 Earnings Call
BIIB Stock | Biogen Inc Q3 2025 Earnings Call
Biogen's Alzheimer's drug gets full FDA approval
Biogen's Alzheimer's drug gets full FDA approval
Pharmaceutical Manufacturing at Biogen
Pharmaceutical Manufacturing at Biogen
Biogen groundbreaking in RTP
Biogen groundbreaking in RTP
Biogen Inc. Behavior - Episode #735
Biogen Inc. Behavior - Episode #735
US FDA approves Biogen Inc's drug for Alzheimer's disease
US FDA approves Biogen Inc's drug for Alzheimer's disease